Pulmonary fibrolysis in a patient with idiopathic pulmonary fibrosis: improvement of clinical and radiological pattern after treatment with pirfenidone

被引:3
|
作者
Varone, Francesco [1 ]
Mastrobattista, Annelisa [1 ]
Franchi, Paola [2 ]
Viglietta, Luca [1 ]
Poletti, Venerino [3 ,4 ]
Tomassetti, Sara [3 ]
Dubini, Alessandra [5 ]
Tagliaboschi, Linda [1 ]
Calandriello, Lucio [2 ]
Farchione, Alessandra [2 ]
Larici, Anna Rita [2 ]
机构
[1] Catholic Univ, A Gemelli Hosp, Cardiothorac Dept, Pulmonol Unit, Rome, Italy
[2] Catholic Univ, A Gemelli Hosp, Inst Radiol, Dept Bioimaging & Radiol Sci, Rome, Italy
[3] GB Morgagni L Pierantoni Hosp, Dept Dis Thorax, Forli, Italy
[4] Aarhus Univ Hosp, Dept Resp Dis & Allergol, Aarhus, Denmark
[5] GB Morgagni L Pierantoni Hosp, Pathol Unit, Forli, Italy
关键词
idiopathic pulmonary fibrosis; high-resolution computed tomography; honeycombing; multidisciplinary team; pirfenidone; DIAGNOSIS;
D O I
10.1111/crj.12515
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive, fibrosing interstitial pneumonia associated with the histologic and/or radiologic pattern of usual interstitial pneumonia (UIP). Nowadays, the high-resolution computed tomography pattern of definite UIP is enough to define a diagnosis of UIP without histological proof. This is pivotal especially in elderly patients with comorbidities. Early recognition of IPF is relevant for its prognostic implication. Some pharmacological strategies have been proposing novel molecules that tend to slow lung function decline, even though without healing fibrosis. We report a case of ex-heavy smoker male with IPF showing clinical and radiological improvement after 11 months of treatment with Pirfenidone. The definite diagnosis was challenging and it was reached by a multidisciplinary approach.
引用
收藏
页码:347 / 351
页数:5
相关论文
共 50 条
  • [41] Clinical Experience of the Long-term Use of Pirfenidone for Idiopathic Pulmonary Fibrosis
    Bando, Masashi
    Yamauchi, Hiroyoshi
    Ogura, Takashi
    Taniguchi, Hiroyuki
    Watanabe, Kentaro
    Azuma, Arata
    Homma, Sakae
    Sugiyama, Yukihiko
    INTERNAL MEDICINE, 2016, 55 (05) : 443 - 448
  • [42] Pirfenidone vs nintedanib for treatment of idiopathic pulmonary fibrosis in clinical practice: efficacy, tolerability, and adverse effects
    Sadon, Amal A. E-A
    Kenawy, Ahmed S.
    Abdelsalam, Ashraf H.
    Attia, Hosam M.
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2020, 69 (03): : 549 - 559
  • [43] Engineering of Stimulus-Responsive Pirfenidone Liposomes for Pulmonary Delivery During Treatment of Idiopathic Pulmonary Fibrosis
    Han, Meishan
    Song, Yingjian
    Liu, Sha
    Lu, Xiaoyan
    Su, Linyu
    Liu, Meixuan
    Zhu, Xiaosu
    Sun, Kaoxiang
    Lu, Yanan
    Wang, Aiping
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [44] Development and utility of pirfenidone in the treatment of idiopathic pulmonary fibrosis: review of preclinical science and recent clinical trials
    Jackson, Robert M.
    Gomez-Marin, Orlando
    TRANSPLANT RESEARCH AND RISK MANAGEMENT, 2011, 3 : 55 - 63
  • [45] Pharmacological treatment of idiopathic pulmonary fibrosis - preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine
    Myllarniemi, Marjukka
    Kaarteenaho, Riitta
    EUROPEAN CLINICAL RESPIRATORY JOURNAL, 2015, 2 (01):
  • [46] Adoption of the Antifibrotic Medications Pirfenidone and Nintedanib for Patients with Idiopathic Pulmonary Fibrosis
    Dempsey, Timothy M.
    Payne, Stephanie
    Sangaralingham, Lindsey
    Yao, Xiaoxi
    Shah, Nilay D.
    Limper, Andrew H.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (07) : 1121 - 1128
  • [47] Effectiveness and safety of pirfenidone for idiopathic pulmonary fibrosis
    Marcos Ribes, Borja
    Sancho-Chust, Jose N.
    Talens, Amparo
    Arlandis, Mar
    Herraiz, Paola
    Chiner, Eusebi
    Aznar, Teresa
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2020, 27 (06) : 350 - 354
  • [48] Predictors of efficacy of pirfenidone in idiopathic pulmonary fibrosis
    Kataoka, Kensuke
    Taniguchi, Hiroyuki
    Kondoh, Yasuhiro
    Kimura, Tomoki
    Matsuda, Toshiaki
    Yokoyama, Toshiki
    Yamano, Yasuhiko
    Nakahara, Yoshio
    Yagi, Mitsuaki
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [49] Pirfenidone-induced photo-allergic reaction in a patient with idiopathic pulmonary fibrosis
    Park, Min-Young
    Shim, Woo-Haing
    Kim, Jeong-Min
    Kim, Gun-Wook
    Kim, Hoon-Soo
    Ko, Hyun-Chang
    Kim, Moon-Bum
    Kim, Byung-Soo
    PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2017, 33 (04) : 209 - 212
  • [50] Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF)
    Balestro, Elisabetta
    Turato, Graziella
    Biondini, Davide
    Pavanello, Sofia
    Fraccaro, Alessia
    Rigobello, Chiara
    Bazzan, Erica
    Campisi, Manuela
    Baraldo, Simonetta
    Cosio, Manuel
    Saetta, Marina
    Spagnolo, Paolo
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48